IBO stock · MSFT stock · Lician Pro · $19.99/mo or $149/yr
IBO vs MSFT · $7.6M cap vs $3.71T cap
Impact BioMedical, Inc. (IBO) versus Microsoft Corporation (MSFT) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) common stock.
Microsoft Corporation (MSFT) common stock.
IBO does not have a complete income-statement cache yet.
MSFT does not have a complete income-statement cache yet.
IBO currently screens at market cap $7.6M. MSFT currently screens at market cap $3.71T.
Not investment advice. Open the IBO and MSFT stock pages for the full models.
Basic comparison
Price, market cap, and trailing P/E stay on this page.
| Metric | IBO | MSFT |
|---|---|---|
| Price | $2.68 | $529.05 |
| Market cap | $7.6M | $3.71T |
| Trailing P/E | — | — |
Deeper peer metrics
Net income and multi-year revenue growth are the peek. More peer metrics open below. This block stops at the labels.
| Metric | IBO | MSFT |
|---|---|---|
| Net income | Pro | Pro |
| Revenue growth | Pro | Pro |
More peer metrics
Operating margin, EPS, free cash flow, and gross margin are on Pro.
IBO vs MSFT comparison FAQ
What is IBO's market cap?
Impact BioMedical, Inc. (IBO) currently screens at market cap $7.6M.
What is MSFT's market cap?
Microsoft Corporation (MSFT) currently screens at market cap $3.71T.
How many IBO vs MSFT comparison scalars are listed on this page?
This page lists 2 cached comparison scalars for IBO vs MSFT: IBO market cap and MSFT market cap.
Where is the IBO vs MSFT comparison listed?
The cached IBO vs MSFT comparison is listed at https://lician.com/compare/ibo-vs-msft.
Not investment advice.